Sensibility Test of Candida species against Nystatin, Ketoconazole, and Fluconazole on Oral Candidiasis with HIV/AIDS using Disc Diffusion Method

Cut Shelma Maharani, Rahmadewi Rahmadewi, Afif Nurul Hidayati, Dwi Murtiastutik

= http://dx.doi.org/10.20473/bikk.V32.3.2020.221-231
Abstract views = 325 times | downloads = 125 times

Abstract


Background: Oral candidiasis is one of the most common infections in Human Immunodeficiency Virus/Acquired Immuno Deficiency Syndrome (HIV/AIDS) patients. Some studies have reported an increased number of resistances of Candida sp. against several antifungal therapies. Purpose: To evaluate the pattern of Candida sp. causing oral candidiasis and the pattern of resistance among the Candida sp. against nystatin, ketoconazole, and fluconazole in oral candidiasis patients with HIV/AIDS infection. Methods: This was a descriptive observational study conducted at the Infectious Disease Intermediate Care Unit (UPIPI) Dr. Soetomo General Academic Teaching Hospital. Candida sp. was identified using conventional methods, while the sensibility test was done by using disc diffusion methods. Result: There were 26 subjects with 50 isolates of Candida sp. that had been cultured successfully. Non-albicans Candida sp. was the most common species, which was observed in 28 subjects (56%). The results of the sensibility test on Candida sp. against nystatin, ketoconazole, and fluconazole were 0 (0%), 3(6%), dan 23(46%) respectively. Conclusion: The increased resistance among Candida sp. against antifungal drugs, especially fluconazole, could raise awareness in drug prescription, especially for HIV/AIDS patients.


Keywords


sensibility test; Candida sp.; antifungals; oral candidiasis;

Full Text:

PDF

References


Das P, Horton R. The cultural challenge of HIV/AIDS. Lancet 2013; 380: 309–10.

Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan Kementerian Kesehatan. Situasi penyakit HIV & AIDS di Indonesia. Jakarta: Ditjen PP & PL Kementerian Kesehatan RI; 2016. Available from: http://www.pusdatin.kemenkes.go.id/ (Accessed: 6 September 2017)

Maheshwari M, Kaur R, Chadha S. Candida species prevalence profile in HIV seropositive patients from a major tertiary care hospital in New Delhi, India. J Pathog 2016: 1-8.

Moges B, Bitew A, Shewaamare A. Spectrum and the in vitro antifungal susceptibility pattern of yeast isolates in Ethiopian HIV patients with oropharyngeal candidiasis. Int J Micro 2016: 1-8.

Dewi ISL, Hidayati AN. Manifestasi kelainan kulit pada pasien HIV dan AIDS. BIKKK 2015; 27(2): 97-105.

Kundu RV, Garg A. Yeast Infection: Tinea (Pityriasis) Versicolor, Malassezia (Pityrosporum) Folliculitis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012. p. 2298-311.

Nadeem SG, Hakim ST, Kazmi SU. Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Libyan J Med 2010; 5:2144-50.

Sariguzel FM, Berk E, Koc An, Sav H, Aydemir G. Evaluantion of CHROMagar Candida, Vitek 2 YST and Vitek MS for identification of Candida strains isolated from blood cultures. Infez Med 2015; 23(4): 318-22.

Kaur R, Dhakad MS, Goyal R, Haque A, Mukhopadhyay G. Identification and antifungal susceptibility testing of Candida species: a comparison of Vitek‐2 system with conventional and molecular methods. J Glob Infect Dis 2016; 8(4): 139-46.

Suyoso S, Ervianti E, Barakbah J. Kandidiasis mukosa. Dalam: Suyoso S, Ervianti E, Barakbah J, editors. Panduan Praktik Klinis SMF Ilmu Kesehatan Kulit dan Kelamin RSUD Dr. Soetomo, Surabaya 2014. h. 95-7.

Saraswati A, Adiguna MS. Resistensi antijamur dan strategi untuk mengatasi. MDVI 2013; 40(2): 89-95.

Reza NR, Sugiman T, Basuki S. Uji kepekaan in vitro flukonazol terhadap spesies Candida penyebab kandidiasis oral pada pasien HIV/AIDS dengan Vitek II. BIKKK 2017; 29(3): 234-42.

Nelwan EJ, Indrasanti E, Sinto R, Nurchaida F, Sosrosumihardjo R. Antifungal susceptibility testing in HIV/AIDS patients: a comparison between automated machine and manual method. Acta Med Indones-Indones J Intern Med 2016; 48(1): 35-40.

Pfaller MA. Antifungal susceptibility testing. Waltham, MA: UpToDate Inc; 2017. Available from: http://www.uptodate.com (Accessed on December 02, 2017.)

Suyoso S. Kandidiasis Mukosa. Dalam: Bramono K, Suyoso S, Indriatmi W, Ramali LM, Widaty S, Ervianti E, editors. Dermatomikosis superfisialis pedoman dokter dan mahasiswa kedokteran. Edisi ke-2. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2013. h: 120-48.

Yowel, Waluyo A, Kuntarti K. Umur Orang Dengan HIV AIDS (ODHA) Berhubungan Dengan Tindakan Pencegahan Penularan HIV. J Keperawatan Indones 2016; 19(3): 200–7.

Khan L, Kumar D, Muralidhar S, Banerjee U, Basir S, Mathur P. Diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic Human Immunodeficiency Virus-infected individuals, and their relation to CD4 + counts. Indian J Sex Transm Dis AIDS 2015; 36(1): 53–8.

Dar MS, Sreedar G, Shukla A, Gupta P, Rehan AD, George J. An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and Human Immunodeficiency Virus seronegative individuals in Lucknow population Uttar Pradesh. J Oral Maxillofac Pathol 2015; 19(2): 205–11

Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Groß U, Mshana SE. Oral candidiasis among African Human Immunodeficiency Virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. J Oral Microbiol 2017; 9(1): 1317579.

Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Groß U, et al. High oral carriage of Non-albicans Candida spp. among HIV-infected individuals. Int J Infect Dis 2016; 49: 185–8.

Canuto MM, Rodero FG. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002; 2(September): 550–63.

Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD, et al. Azole antifungal resistance in Candida albicans and emerging non- albicans Candida species. Front Microbiol 2017; 7(January): 1–12.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Berkala Ilmu Kesehatan Kulit dan Kelamin

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

 

Lisensi Creative Commons
Creations are distributed below Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

View My Stats